Pieracci FM et al. |
A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*. |
2014 |
Crit. Care Med. |
pmid:24797376
|
Hetzel D et al. |
A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. |
2014 |
Am. J. Hematol. |
pmid:24639149
|
Perelló MF et al. |
Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. |
2014 |
BJOG |
pmid:24423186
|
Toyokuni S |
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis. |
2014 |
Redox Rep. |
pmid:24257681
|
Elford P et al. |
Biodistribution and predictive hepatic gene expression of intravenous iron sucrose. |
2013 Nov-Dec |
J Pharmacol Toxicol Methods |
pmid:23624021
|
Soufras GD et al. |
Fatal anaphylactic reaction to iron sucrose in pregnancy: iron-induced Kounis syndrome? |
2013 Nov-Dec |
Indian J Pharmacol |
pmid:24347784
|
Mishra A et al. |
Fatal anaphylactic reaction to iron sucrose in pregnancy. |
2013 Jan-Feb |
Indian J Pharmacol |
pmid:23543624
|
Palmer K et al. |
Review of available intravenous iron preparations in hemodialysis. |
2013 Apr-Jun |
CANNT J |
pmid:24069699
|
Wilson PD et al. |
An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic. |
2013 |
J Med Econ |
pmid:22989163
|
|
Ferumoxytol: an intravenous iron, riskier than iron sucrose. |
2013 |
Prescrire Int |
pmid:24171212
|